 |
Articles: General Pharma |
Prior Articles
Pixantrone Produces High Rates of Complete Remission in Multiple Relapsed and Refractory Indolent and Aggressive Non-Hodgkins Lymphoma
Cell Therapeutics, 11/04/09
Free full text
Cytokinetics to Present at November Healthcare Conferences
Cytokinetics, 11/04/09
Free full text
Worlds largest malaria vaccine trial now underway in seven African countries
GlaxoSmithKline, 11/04/09
Free full text
Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in Patients with Chronic Constipation
Forest Laboratories, 11/04/09
Free full text
PHR Supports Medical Tourism
HealthDataManagement, 11/04/09 Third quarter 2009 report - Lundbeck records 20% growth, driven by Lundbeck Inc. and key products
Lundbeck, 11/04/09
Free full text
Allos Therapeutics Reports Third Quarter 2009 Financial Results
Allos Therapeutics, 11/04/09
Free full text
Nabi Biopharmaceuticals Initiates Pivotal Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence
Nabi Biopharmaceuticals, 11/04/09
Free full text
Bristol-Myers Squibb Donation to Benefit Students at The Pennington School and Beyond
Bristol Myers-Squibb Company, 11/04/09
Free full text
ACTEMRA inhibits progression of joint destruction in RA patients by over 80% compared to methotrexate alone
Chugai Pharmaceutical Co., 11/04/09
Free full text
Nabi Biopharmaceuticals Announces Withdrawal of Biotests Indemnification Claim
Nabi Biopharmaceuticals, 11/04/09
Free full text
Enzon Reports Third Quarter Results
Enzon Pharmaceuticals, 11/04/09
Free full text
HIE, Diagnostic Imaging Vendors Align
HealthDataManagement, 11/04/09 Dendreon Completes Submission of Biologics License Application for PROVENGE
Dendreon Coproration, 11/03/09
Free full text
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Free full text
Abbotts XIENCE PRIME and XIENCE V Receive Indications in Europe for Treatment of Patients with Diabetes
Abbott, 11/03/09 Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc
American Pharmaceutical Partners, 11/03/09
Free full text
Gilead Sciences Announces Plans for Phase IV Clinical Trial Evaluating First-Line Combination Therapy Versus Monotherapy in Pulmonary Arterial Hypertension
Gilead, 11/03/09
Free full text
ARIADs AP24534 Featured in Cancer Cell Publication as a Potential First-in-Class Pan BCR-ABL Inhibitor
ARIAD Pharmaceuticals, 11/03/09
Free full text
Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder
Cephalon, 11/03/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
